Women’s Health

Veozah Approved for Moderate to Severe Vasomotor Symptoms Due to Menopause

Veozah is an oral neurokinin 3 (NK3) receptor antagonist.

FDA Panel Supports Rx-to-OTC Switch of Progestin-Only Birth Control Pill

A decision on the OTC oral contraceptive pill is expected later this year.

Fezolinetant Reduces Vasomotor Symptoms in Menopause

The safety and efficacy of fezolinetant in the treatment of menopause-related vasomotor symptoms were assessed.

Interrupting Therapy for Pregnancy Did Not Increase Risk of Breast Cancer Recurrence

Interrupting adjuvant endocrine therapy to attempt pregnancy does not increase the risk of breast cancer recurrence, a study suggests.

Fracture Risk Reduction Greater With Denosumab vs Alendronate, According to Real-World Data

Treatment with Prolia was associated with greater reductions in the overall relative risk across various fracture types.

Timing of Menopause, Hormone Therapy Initiation Tied to Tau Vulnerability in Women

Researchers sought to determine the extent in which sex, age at menopause, and hormone therapy use are associated with regional tau at a given level of Aβ — both measured with PET.

Loneliness Common Among Women Experiencing Perinatal Depression

Investigators searched publication databases from inception through to July 2021 for studies about loneliness in the perinatal setting for this meta-synthesis.

FDA Sets Date to Discuss Over-the-Counter Birth Control Pill

If approved, Opill would be the first daily oral contraceptive pill available without a prescription.

Plant-Based Diets Protective Against Osteoporosis Among Older Adults, Women

Researchers studied the link between plant-based dietary patterns and osteoporosis among older adults.

Why Women May Have a Higher Risk of Developing Dementia Than Men

In an international meta-analysis, researchers evaluated sex differences in all-cause dementia risk across diverse ethno-regional groups.

Meta-Analysis Indicates Safety and Effectiveness of COVID-19 Vaccination During Pregnancy

Researchers evaluated the effectiveness and safety of COVID-19 vaccination during pregnancy.

Hormone Replacement Therapy as a Potential Alzheimer Disease Preventive Strategy 

Researchers sought to assess the role of APOE genotype and age at HRT initiation on the heterogeneity in cognitive response to HRT.

COVID-19 Vaccination May Negatively Affect Menstruation

Researchers evaluated changes in menstruation following COVID-19 vaccination.

Emzahh Gets FDA Approval for Pregnancy Prevention

Emzahh is an AB-rated generic equivalent of Ortho Micronor.

Reforming Institutions, Integrating Health Technology to Address Maternal Mortality Gap

Experts discuss strategies to reduce the maternal mortality gap by implementing implicit bias training and reevaluating clinical guidelines and algorithms.

FDA Allows Certified Retail Pharmacies to Dispense Mifepristone

Mifepristone is a progestin antagonist indicated, in a regimen with misoprostol, for the medical termination of intrauterine pregnancy through 70 days gestation.

Maternal Mortality Crisis Among Minority Patients in the US

ACOG experts provide actionable steps to reduce the maternal mortality crisis in the US, particularly among minority populations.

HCPs May Not Fully Investigate Heavy Menstrual Bleeding Among Women and Girls

Researchers sought to investigate whether health care providers investigated heavy menstrual bleeding as a potential symptom of an underlying bleeding disorder.

FDA Approves Brexafemme for Recurrent Vulvovaginal Candidiasis

Brexafemme is an oral antifungal agent representing a novel therapeutic class of structurally-distinct glucan synthase inhibitors known as triterpenoids.

High Incidence of Anticoagulation-Associated Abnormal Menstrual Bleeding in Women After Venous Thromboembolism

Researchers sought to determine whether there was a link between abnormal menstrual bleeding and treatment with anticoagulants for VTE.